PROGRESSIVE AGGREGATION DESPITE CHAPERONE ASSOCIATION
PROGRESSIVE AGGREGATION DESPITE CHAPERONE ASSOCIATION
批准号:
8171476
负责人:
ARTHUR L HORWICH
金额:
$0.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2011-08-31
关键词:
AgeAge-MonthsAmyotrophic Lateral SclerosisAnimalsBiochemicalComputer Retrieval of Information on Scientific Projects DatabaseEnzymesFundingGel ChromatographyGrantGuanine Nucleotide Exchange FactorsHumanIn SituInstitutionIntermediate Filament ProteinsLinkMass Spectrum AnalysisMolecular ChaperonesMotorMotor NeuronsMusNucleotidesParalysedProcessRNAResearchResearch PersonnelResourcesSourceSpinal CordSpinal cord grey matter structureSymptomsTimeTransgenic AnimalsTransgenic OrganismsUnited States National Institutes of Healthmonomermutantneuronal cell bodyprotein misfoldingsuperoxide dismutase 1
中文摘要
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
最近的研究表明超氧化物歧化酶 1 (SOD1) 相关的肌萎缩侧索硬化
硬化是由于这种丰富的突变形式的不稳定和错误折叠造成的
胞质酶。在这里,我们追踪了一个容易折叠错误的人的表情和命运
人类 SOD1,G85R,与 YFP 融合,存在于转基因 G85R SOD1-YFP 小鼠系中。这些老鼠,
但不是野生型人类 SOD1-YFP 转基因,开发出致命的麻痹运动
9个月时出现症状。脊髓原位 RNA 杂交显示主要
在所有转基因动物的脊髓灰质运动神经元中表达。
一致地,G85R SOD-YFP 在 1 和 1 时在动物运动神经元中发出弥漫性荧光。
6个月大,但在出现症状时,细胞内观察到点状聚集物
机构和过程。脊髓可溶性提取物的生化分析表明
G85R SOD-YFP 在所有年龄段都表现为错误折叠的单体。逐渐变成了
在 6 个月和 9 个月大时不溶,与可观察到的可溶性低聚物的存在有关
通过凝胶过滤。免疫亲和捕获和质谱分析揭示了
G85R SOD-YFP,但不是 WT SOD-YFP,在所有年龄段均具有胞质伴侣 Hsc70。在
此外,在 6 和 9 处捕获了 3 个 Hsp110(Hsp70 的核苷酸交换因子)
几个月。尽管存在这种伴侣相互作用,G85R SOD-YFP 在
晚期,主要含有中间丝蛋白。我们的结论是
运动神经元最初“补偿”以维持错误折叠的蛋白质处于可溶状态,
逐渐无法做到这一点。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Recent studies suggest that superoxide dismutase 1 (SOD1)-linked amyotrophic lateral
sclerosis results from destabilization and misfolding of mutant forms of this abundant
cytosolic enzyme. Here, we have tracked the expression and fate of a misfolding-prone
human SOD1, G85R, fused to YFP, in a line of transgenic G85R SOD1-YFP mice. These mice,
but not wild-type human SOD1-YFP transgenics, developed lethal paralyzing motor
symptoms at 9 months. In situ RNA hybridization of spinal cords revealed predominant
expression in motor neurons in spinal cord gray matter in all transgenic animals.
Concordantly, G85R SOD-YFP was diffusely fluorescent in motor neurons of animals at 1 and
6 months of age, but at the time of symptoms, punctate aggregates were observed in cell
bodies and processes. Biochemical analyses of spinal cord soluble extracts indicated that
G85R SOD-YFP behaved as a misfolded monomer at all ages. It became progressively
insoluble at 6 and 9 months of age, associated with presence of soluble oligomers observable
by gel filtration. Immunoaffinity capture and mass spectrometry revealed association of
G85R SOD-YFP, but not WT SOD-YFP, with the cytosolic chaperone Hsc70 at all ages. In
addition, 3 Hsp110's, nucleotide exchange factors for Hsp70s, were captured at 6 and 9
months. Despite such chaperone interactions, G85R SOD-YFP formed insoluble inclusions at
late times, containing predominantly intermediate filament proteins. We conclude that
motor neurons, initially "compensated" to maintain the misfolded protein in a soluble state,
become progressively unable to do so.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURE FUNCTION STUDIES ON GROEL WITH AND WITHOUT SUBSTRATE
-
批准号:8362455
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2011
-
负责人:ARTHUR L HORWICH
-
依托单位:
STRUCTURE FUNCTION STUDIES ON GROEL WITH AND WITHOUT SUBSTRATE
-
批准号:8169675
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2010
-
负责人:ARTHUR L HORWICH
-
依托单位:
STRUCTURE FUNCTION STUDIES ON GROEL WITH AND WITHOUT SUBSTRATE
-
批准号:7956440
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2009
-
负责人:ARTHUR L HORWICH
-
依托单位:
STRUCTURE FUNCTION STUDIES ON GROEL WITH AND WITHOUT SUBSTRATE
-
批准号:7723572
-
项目类别:
-
资助金额:$2.53万
-
财政年份:2008
-
负责人:ARTHUR L HORWICH
-
依托单位:
TRANSIENT STRUCTURAL STATES OF GROEL
-
批准号:7721719
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2008
-
负责人:ARTHUR L HORWICH
-
依托单位:
STRUCTURE FUNCTION STUDIES ON GROEL WITH AND WITHOUT SUBSTRATE
-
批准号:7602759
-
项目类别:
-
资助金额:$3.58万
-
财政年份:2007
-
负责人:ARTHUR L HORWICH
-
依托单位:
Chaperonin-mediated protein folding
-
批准号:7108010
-
项目类别:
-
资助金额:$27.49万
-
财政年份:2004
-
负责人:ARTHUR L HORWICH
-
依托单位:
Chaperonin-mediated protein folding
-
批准号:6936565
-
项目类别:
-
资助金额:$28.16万
-
财政年份:2004
-
负责人:ARTHUR L HORWICH
-
依托单位:
CRYO EM STUDIES OF ACONITASE BOUND TO GROEL
-
批准号:6979100
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2004
-
负责人:ARTHUR L HORWICH
-
依托单位:
Chaperonin-mediated protein folding
-
批准号:7279326
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2004
-
负责人:ARTHUR L HORWICH
-
依托单位:
Chaperonin-mediated protein folding
-
批准号:6815644
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2004
-
负责人:ARTHUR L HORWICH
-
依托单位:
FUNCTION OF GROEL IN THE BACTERIAL CYTOPLASM
-
批准号:2177414
-
项目类别:
-
资助金额:$12.79万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
GROEL-MEDIATED PROTEIN FOLDING
-
批准号:6125283
-
项目类别:
-
资助金额:$17.08万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
TARGETING OF HUMAN OTC TO THE MITOCHONDRIAL MATRIX
-
批准号:3285390
-
项目类别:
-
资助金额:$17.34万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
TARGETING OF HUMAN OTC TO THE MITOCHONDRIAL MATRIX
-
批准号:3285392
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
TARGETING OF HUMAN OTC TO THE MITOCHONDRIAL MATRIX
-
批准号:3285391
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
EXPRESSION OF CDNA FOR HUMAN ORNITHINE TRANSCARBAMYLASE
-
批准号:3285386
-
项目类别:
-
资助金额:$2.89万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
EXPRESSION OF CDNA FOR HUMAN ORNITHINE TRANSCARBAMYLASE
-
批准号:3285383
-
项目类别:
-
资助金额:$11.02万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
MECHANISM OF ACTION OF THE HSP100 CHAPERONE CLPA
-
批准号:6625041
-
项目类别:
-
资助金额:$16.35万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位:
MECHANISM OF ACTION OF THE HSP100 CHAPERONE CLPA
-
批准号:6685240
-
项目类别:
-
资助金额:$16.35万
-
财政年份:1984
-
负责人:ARTHUR L HORWICH
-
依托单位: